Search Results
Substituting trastuzumab emtansine for adjuvant trastuzumab improved IDFS for breast cancer pati...
Improved IDFS for breast cancer patients who received trastuzumab emtansine
Adjuvant trastuzumab emtansine vs paclitaxel and trastuzumab for HER2-positive breast cancer
A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers
Adjuvant T-DM1 for HER 2+ Breast Cancer: Critical Data From The KATHERINE Study
Reducing Risk in Residual Breast Cancer
KATHERINE trial updates for HER2-positive breast cancer
Dr. Tripathy on Neoadjuvant Treatment Strategies in HER2+ Breast Cancer
Dr. Vidal on Potential of [Fam-] Trastuzumab Deruxtecan in HER2+ Breast Cancer
Dr. Hamilton Discusses the KATHERINE Trial in HER2+ Breast Cancer
Trastuzumab emtansine,HER2-targeted therapies
Dr. Geyer on the Rationale for the KATHERINE Trial in HER2-Positive Breast Cancer
![Dr. Vidal on Potential of [Fam-] Trastuzumab Deruxtecan in HER2+ Breast Cancer](https://img.youtube.com/vi/P983Z-Fs3fI/hqdefault.jpg)
